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Purpose. The aim of this study was to determine the value of 3D and 3D Power Doppler sonography in the detection of tumor
malignancy in breast lesions and to ﬁnd new diagnostic criteria for diﬀerential diagnosis. Methods. One hundred and twenty ﬁve
women with clinically or mammographically suspicious ﬁndings were referred for 3D Power Doppler ultrasound prior to surgery.
Histological diagnosis was conducted after surgery and compared with ultrasound ﬁndings. Sonographic criteria used for breast
cancer diagnosis were based on a system that included morphological characteristics and criteria of the vascular pattern of a breast
mass by Power Doppler imaging. Results. Seventy-two lesions were histopathologically diagnosed as benign and 53 tumors as
malignant. Three-dimensional ultrasound identiﬁed 49 out of 53 histologically conﬁrmed breast cancers resulting in a sensitivity
of 92.4% and a speciﬁcity of 86.1% in diagnosing breast malignancy (PPV: 0.83, NPV:0.94). Conclusions. 3D ultrasonography is a
valuable tool in identifying preoperatively the possibility of a tumor to be malignant.
Copyright © 2009 K. Kalmantis et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Mammographyistheonlywellestablishedscreeningmethod
for the detection of breast cancer. Today, the aim of
diﬀerentiating malignant from benign breast tumors and
diagnosing early breast cancers is more accurately fulﬁlled
with the addition of ultrasound scan. It has been reported
that combined mammography and sonomammography to
womenwithdensebreastsorotherhigh-riskfactors,resultto
a higher sensitivity in breast cancer diagnosis [1, 2]. Modern,
high resolution breast ultrasonography presents the ability
of depicting even mammographically occult, asymptomatic
breast cancers [3]. Ultrasonographic sensitivity is not con-
ﬁned of dense breast tissue and it is an extremely useful
modality for breast imaging in young and pregnant women
[4, 5].
Real-time ultrasonography experience over the years
and high quality imaging technology made possible the
establishment of certain criteria of tumor examination. The
assessment of the tumor shape, orientation, the deﬁnition of
tumormarginsandthepresenceorabsenceofretractionpat-
tern remain the most acceptable and sensitive diﬀerentiating
markers of malignancy [6].
3D mammasonography is the most recent development
in breast ultrasound imaging, providing additional aspects
to conventional 2D sonography. New superior diagnostic
information such as the ability to study a breast mass and
the surrounding tissue in three orthogonal planes with high
frequency transducers, overcomes anatomical limitations
which restrict the number and orientation of the scanning
planes and allows an objective analysis of breast tumor
morphology and angiogenesis [7].
New Doppler methods, such as Power Doppler, obtain
better results that conventional Doppler in detecting vas-
cularity of solid breast masses and allow more detailed
depictions of vessel structure and tissue vascularity in slow
and poor ﬂow areas. Neovascularization of a carcinoma
with an irregular vascular pattern, arteriovenous shunts
and missing vessel autoregulation—in contrast to normal
breast tissue vessels—aims to diﬀerentiate between benign2 Obstetrics and Gynecology International
and malignant breast tumors [8]. However, the proof of
extent of tumor vascularity is not a suﬃcient criterion
for diﬀerential diagnosis and identiﬁcation of fast growing
tumoral capillaries has not gained clinical relevance until
now [9, 10].
3D Ultrasound facilities and 3D Power Doppler are addi-
tionalandnoreplacingmodalitiestobreastultrasoundimag-
ing. Today, there is no certain data available of superiority of
3D techniques over the classic sonomammography in breast
cancer diagnosis [11, 12]. Nevertheless, with these “high-
end” techniques, the ﬁnal imaging is improved, adding this
way a diagnostic advantage to clinical or mammographical
suspicion or exclusion of malignancy and proper treatment
plan. However, diagnosis may remain uncertain for some
breast tumors that exhibit variable sonographic character-
istics due to diﬀerences in histological type, histological
grading and tissue components within the tumors.
In order to avoid unnecessary biopsies but without
missing cancers, or to better plan an operation, new
diagnostic procedures are sought. The combined use of
mammography and 3D imaging may have clinical utility in
the early detection of breast cancer. The goal of this study
was to estimate the diagnostic value of this new method in
distinguishing benign from malignant breast lesions.
2.MaterialsandMethods
One hundred and ﬁfty three patients with palpable breast
masses or abnormal mammograms underwent ultrasound
and 3D Power Doppler ultrasound scan, in order to
diﬀerentiate malignant from benign lesions preoperatively.
Patients were recruited consequently from April 2007 to
November2007andwerereferredtoourbreastcancercenter
for further evaluation of the mass and treatment. Twenty
eight patients were not eligible and were excluded from the
study because clinically or mammographic lesions were not
visible on ultrasound or, they had cysts or, tumors were
too big for 3D ultrasound or, patients gave no informed
consent. The remaining 125 women, aged 18 to 70 years
(mean age 45 years), had solid tumors and after clinical
evaluation and ultrasonography, they were treated surgically
with open excisional biopsy. In this study we compare pri-
mary ultrasonographic characteristics and diagnoses before
surgery to histopathological ﬁndings after surgery. No data
of preoperative cytologic results is included.
For the ultrasound scans we used a 3D ultrasound
volume transducer 5–13Mhz with a 30◦ volume sector,
Voluson 730 Pro, General Electric. Ultrasound examina-
tion was performed with patients in supine position with
elevated arms by two sonographers experienced in breast
ultrasound. Ultrasound examiners were not aware of clinical
andmammographicﬁndings.Oncetheregionofinteresthad
been identiﬁed the volume box was superimposed and the
ultrasound probe was kept steady. The volume mode was
switched on and the 3D ultrasound volume was generated
by the automatic rotation of the mechanical transducer
through 360◦. The acquisition time ranged between 2–4
seconds depending on the size of the volume box. Three
perpendicular planes were displayed simultaneously thus
enabling better understanding of the morphology of breast
lesion. Evaluation of the stored volumes took 10–15 minutes,
depending on the number of slices, rotation angle and
rendering modes used. Since the number and orientation of
reformattedplanedarenotlimited meticulousevaluationsof
numerous sections thorough the tumour becomes possible.
Ultrasound examination evaluated suspicious lesions for
their shape, orientation, margins, the echogenicity of the
lesion and the surrounding tissue, echotexture, acoustic
transmission, pattern, and vessel’s architecture (Table 1).
Additionally, Pourcelot resistance index (RI) was used as
the calculated measurements of the ﬂow velocity wave form
(systole minus diastole divided by systole). The Doppler
variable used for diagnosing breast malignancy was RI ≤
0.42 obtained from the periphery or from central areas of the
tumor.
Benign ultrasound characteristics as round-oval shape
and a long axis parallel to skin were scored by 0 and
malignant characteristics as inhomogenous echotexture and
a star pattern in the coronary plane were scored by 2.
The scoring system was used for each one of the above
criteria as it is shown inTable 1. After completing ultrasound
examination, scores for each parameter were added to make
a sum for each patient. The bigger the number the higher is
the possibility for malignancy. We used 6 as the cutoﬀ point
of malignancy. Final score by combined ultrasound imaging
less than 6 (<6) favors a benign lesion while a score of 6 or
more (≥6) assessed as predicting malignancy.
T h e3 Ds o n o g r a p h i cc h a r a c t e r i s t i c su s e dt od i ﬀerentiate
benign from malignant lesions were based on a speciﬁc
scoring system including morphologic characteristics and
criteria of the vascular pattern of a breast mass [13–19].
The ﬁnal ultrasound estimation scores were compared
with histopathology reports of the tumor specimens.
Distributional properties at 3D and 3D Power Doppler
outcomes with respect to the ten criteria that were investi-
gated by chi-square statistics (x2-test).
All patients included in this study were properly
informedbeforesigningawrittenconsentandthestudywere
approved by the ethical committee of the hospital.
3. Results
Seventy-two patients were diagnosed to have benign tumors
(adenoma, ﬁbroadenoma, papilloma, phyllodes tumor,
radialscar,andlipoma)and53malignant(mainlyductaland
lobular, few papillary, mucinous, medullary and tubular car-
cinomas), according to histopathology reports after surgery.
The most common benign breast tumor was ﬁbroadenoma
(Figure 1) while the most common malignant tumor was
ductal carcinoma (Figure 2). The combined use of 3D ultra-
sound and 3D Power Doppler identiﬁed 66 breast tumors as
benign (score < 6) and 59 tumors as malignant (score ≥ 6)
(Table 2). The 3D and 3D Power Doppler ultrasound gave 10
false positive results (2 adenomas, 2 ﬁbroadenomas, 3 radial
scar, and 3 papillomas) and misdiagnosed 4 carcinomas (1
ductal, 1 papillary, 1 medullary, and 1 tubular carcinomas).Obstetrics and Gynecology International 3
Table 1: 3D Ultrasonographic criteria for breast tumors.
(1) Shape
Round/oval 0
Lobular 1
Irregular 2
(2) Orientation
Wider than tall (W > T) 0
Not clear (W = T) 1
Taller than wide (W < T) 2
(3) Margin Well deﬁned 0
ILL deﬁned (microlobulated) 2
(4) Surrounding echogenicity Hypoechogenic regular (pseydocapsule) 0
Echogenic irregular 2
(5) Echogenicity Hyperechoic 0
Hypoechoic 2
(6) Echotexture Homogenous 0
Inhomogenous 2
(7) Acoustic transmission Present (enhancement) 0
Absent 2
(8) Pattern Compression pattern 0
Retraction/star pattern 2
(9) Vessels architecture Linear 0
Chaotic-complex 1
(10) R.I.
≥0.42 0
<0.42 1
Figure 1: 3D pictures of a ﬁbroadenoma.
Table 2: 3D Ultrasound ﬁndings compared with histopathology
reports.
3D Ultrasound Histopathology
Diagnosis Histologicaly conﬁrmed
preoperative diagnoses
Benign 66 62 (86,1%) 72
Malignant 59 49 (92,4%) 53
Total 125 111 (88,8%) 125
Cutoﬀ score greater or equal to 6 was associated with a high
potential for breast malignancy.
Figure 2: 3D reconstruction of an invasive ductal carcinoma
angulated with inhomogenous echotexture and retraction pattern.
In our series, the accuracy of 3D and 3D Power Doppler
ultrasound in assessing a suspicious mammography lesion
appeared high with a sensitivity of 92.5% and a speciﬁcity
of 86.1%. The positive and negative predictive values were
83.1% and 93.9%, respectively. Performance classiﬁcation
was assessed by Receiver Operating Characteristic curve
(ROC): a graphical plot of the sensitivity versus the false
positive rate, (Figure 3).
Combined 2D and 3D Power Doppler sonographic
features of all patients are summarized in Table 3. Distri-
butional properties at 3D and 3D Power Doppler outcome
with respect to the ten criteria were investigated by chi-
square statistics (x2-test). Distinct diﬀerences in imaging4 Obstetrics and Gynecology International
Table 3: 3D outcome according to the sonographic criteria used in our breast tumor patients.
Benign CA
N % N % P
Shape Round/oval 52 72.2% 1 1.9% <.0001
Lobular 20 27.8% 10 18.9%
Irregular 0 0% 42 79.2%
Orientation (W > T) 49 68.1% 4 7.5% <.0001
(W = T) 21 29.2% 5 9.4%
(W < T) 2 2.8% 44 83.0%
Margin Well deﬁned 70 97.2% 13 25% <.0001
ILL deﬁned 2 2.8% 40 75%
Surrounding echogenicity Hypoechogenic regular 72 100.0% 24 45.3% .002
Echogenic irregular 0 0% 29 54.7%
Echogenicity Hyperechoic 63 87.5% 33 62.3% .002
Hypoechoic 9 12.5% 20 37.7%
Echotexture Homogenous 37 51.4% 12 22.6% <.0001
Inhomogenous 35 48.6% 41 77.4%
Acoustic transmission Present 36 50.0% 8 15.1% <.0001
Absent 36 50.0% 45 84.9%
Pattern Compression pattern 69 95.8% 6 11.3% <.0001
Retraction/star pattern 3 4.2% 47 88.7%
Vessels architecture Linear 70 97.2% 25 47.2% <.0001
Chaotic-complex 2 2.8% 28 52.8%
R.I. ≥0.42 70 97.2% 29 54.7% <.0001
<0.42 2 2.8% 24 45.3%
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Figure 3: High diagnostic capability of 3D ultrasound in diﬀeren-
tiating benign from malignant breast tumors.
between malignant and benign tumors were found statis-
tically signiﬁcantly in all of the ten criteria used: benign
tumors appeared in a round/oval shape in 52 cases (72.2%),
with the horizontal diameter wider than the vertical in 49
Figure 4: 3D Power Doppler imaging of a malignant tumor with
chaotic vessels’ architecture and complex branching pattern.
cases (68.1%), with smooth deﬁned margin in 70 cases
(97.2%), with no surrounding echogenicity to all 72 cases
(100%), with hyperechoic echotextures in 63 cases (87.5%),
and with homogenous echotextures in 37 cases (51.4%).
Acoustic transmission was present in 36 cases (50%) and
compression pattern was observed in 69 cases (95.8%).
Malignant tumors, on the contrary, appeared in 3D with
chaotic vessel architecture with complex branching pattern
(Figure 4) in 28 cases (52.8%). The R.I. value was lower than
0.42 in 2 cases of benign (2.8%) and in 24 cases of malignant
tumors (45.3%).Obstetrics and Gynecology International 5
4. Discussion
Mammographic screening is the only screening method
proven to decrease breast cancer mortality. It is understood
that early detection of small subclinical lesions and sub-
sequent surgical treatment is the cornerstone of successful
screening. Throughout the years, additional imaging modal-
itiestomammographyhavebeeninsertedtoclinicalpractice.
One of these is the ultrasound scan of the breasts which
in the beginning helped to diﬀerentiate benign cysts from
solid masses. Today, development of ultrasound technology
and high quality of modern 2D breast sonography resulted
in imaging detailed anatomical structures, and nonpalpable
pathological lesions [20]. Mammasonography is considered
a worthwhile adjunct to mammography in diﬀerentiating
benign from malignant lesions [21, 22]. In a recent study,
addition of ultrasound to mammographic screening resulted
in a 55% increase in breast cancer diagnosis in a high risk
population [23]. These results are expected to reﬂect in a
further reduce of mortality rates in future trials.
Ultrasound screening shows the potential to depict early,
node negative, small sized breast cancers that sometimes
escape mammography illustration and its performance seem
accurateindenseparenchyma[24–26].However,Moonetal.
reported that sonography can depict small or non-palpable
lesions but its accuracy in diagnosis of malignancy is low
[27].
Withincreasingexperienceinbreastultrasoundimaging,
criteria of diﬀerentiation established to increase the accuracy
and achieve a consensus among radiologists when describing
breast abnormalities [13, 28]. Sonomorphological parame-
ters of breast tumors such as shape, tumor margins, internal
echogenicity, echotexture distribution and posterior echo
have been shown to be valuable in the diﬀerential diagnosis
between benign and malignant breast tumors [6, 29].
The shape of a solid tumor is one of the primary features
studied for diﬀerential diagnosis. Oval or royal shape is
considered as a benign characteristic of a solid mass [30].
In our patients a round oval shape was found in 72.2% of
benign breast tumors and only in 1.9% of malignant tumors,
while irregular shape was found in 79.2% of malignant
tumors.Informerstudiestheoval/roundshapecharacterizes
benign tumors in 82,5 to 86% and is found in 24 to 42%
of malignant tumors, depended on the study [30]. This
increased accuracy in our study may be partly explained by
the high quality imaging pictures we have today in breast
ultrasonography.
Appearance of margins and tumor orientation rep-
resent two of the most important tumor features [31].
Spiculated or not deﬁned margins in combination with
abnormal shape and nonparallel orientation of the tumor
are highly susceptive of malignancy. Speculated margins, in
fact, are suggesting of an inﬁltrating process and nonparallel
orientation may be the result of abnormal growth of a
tumor through tissue planes as cancer develops. In contrast,
circumscribed, deﬁned margins and parallel orientation
(with the wide axis larger or equal to the tall axis) of the
lesion are predictive of a benign diagnosis and of a tumor
whichgrowthswithoutinterferingtothesurroundingtissues
[29]. In our study, 75% of breast cancers and 2.8% of benign
tumors had ill deﬁned margins. The nonparallel orientation
was found in 83% of cancer cases and in 2.8% of benign
tumors, giving a sensitivity of 0.83 and a speciﬁcity of 0.97.
These increased sensitivity rates may be the result of the high
quality images of real time ultrasonography in combination
with an increased clinical or mammographical suspicion of
the examined lesion that entailed to increased examiner’s
attention to the tumor characterization.
Invasive tumors tent to appear sonographically inho-
mogenous. Margins are echo-rich because of the variety
of tissue components expressed by the tumor and the
surrounding inﬁltrated parenchyma. Homogenous echo-
poor center is the result of ﬁbrohyalinosis. Dorsal shadowing
frequently depict as a consequence of ultrasound energy
absorption through tumor [32, 33]. Tumor echogenicity,
echotexture and presence of posterior shadowing are con-
sidered important sonographic features in evaluation of
breast lesions [31]. The vast majority of benign tumors in
our sample are hyperechoic and most of malignancies have
inhomogenous echotexture. These criteria are reported to
be important sonographic features suggesting a malignant
tumor and present in 72–97% of breast carcinomas. Also, in
our patients, absence of acoustic transmission was present
in almost 85% of malignant tumors. In contrast, it is
reported in the literature that an internal echo pattern and
echogenicity have a low discriminating value.
3D ultrasound is one of the most recent developments in
breast imaging, providing additional aspects to conventional
2D sonography such as the ability to study a breast mass and
the surrounding tissues in three orthogonal planes. Exceed-
ing the limitation of scanning only 2D planes, 3D ultrasound
imaging modality access the imaging of coronal, transversal
and sagittal planes simultaneously. Transverse and sagittal
plane of the typical 2D ultrasound allow evaluation of
architecture distortions like connective tissue disruption and
changes of shape and orientation. For stellate tumors or
carcinomas with diﬀuse pattern of growth, the malignant
inﬁltration is impressively apparent in coronal plane by 3D,
as a retraction pattern. On the contrary, benign lesions are
associated with a compressive pattern. These two patterns
show high speciﬁcity and sensitivity (0.938 and 0.914, resp.)
and high predictive values (positive 0.869, negative 0.960)
when used as criteria for diﬀerential diagnosis [7, 34]. Even
in small stellate carcinomas with diameter smaller than
1cm, the retraction pattern is visible in the coronal plane.
In the coronal plane, architectural distortion may be the
only imaging ﬁnding of a lobular carcinoma that is not
apparent as a mass in mammography or conventional 2D
sonography [7, 12, 35]. In our series, retraction/stellate
patternwasapparentin88,7%ofmalignantcases(sensitivity
0.89, speciﬁcity 0.96, positive predictive value 0.96, negative
predictive value 0.92) which is close to that reported in the
literature.
3D ultrasonography oﬀers a clear imaging of lesions
with abnormal shapes, like complex ﬁbroadenomas with
lobulation on their surfaces or irregular aspects. Additional
information for the lesion can be collected, like the spatial
distribution of echo texture, related to an echodiﬀerent6 Obstetrics and Gynecology International
area within a ﬁbroadenoma such as calciﬁcation. Another
advantage of this method is that 3D multiplanar image is
independent of the diameter of the long or short axis of the
lesionandangulations,resultinginobjectivemeasurementof
the tumor. With 3D reconstruction and display modes as the
niche mode, transparent maximum and surface mode, extra
data can be collected. These modalities allow the visualiza-
tion of the entire nipple area and the retromamillary region
in one volume obtaining full diagnostic information. It also
demonstrates reliably the ductal anatomy and the pathology
of intraductal components. Sonographic evaluation of the
retromammilary region is considered as the most accurate
imaging modality [36].
Vascularisation of a breast lesion is possible to be exam-
ined using a 3D Power Doppler technique. Neovasculariza-
tion, irregular vascular pattern, arteriovenous shunts and
missing vessel autoregulation are converging to carcinoma
diagnosis. Benign lesions and normal breast tissue lack
of these characteristics [10]. Although the morphological
pattern of tumor vessels can be assessed by a 2D Doppler
sonography, 3D Power Doppler provides the advantage of
visualization of the entire lesion. Additionally, 3D recon-
structions of color volume data oﬀers the ability to examine
the vessel distribution and potential irregularities of vessel
shape. The 3D display of power ﬂow imaging data can
be rotated to facilitate the study of the architecture of
tumor vessels in various projections. Views of the value in
diﬀerent projection of malignant lesions clearly reveal the
feeding vessel and the entire neovascular network intra-
and peritumoraly [10]. Irregular vessel calibers, penetration
of the tumor margins and irregular vascularisation are
suspicious for malignancy [9].
3D Power Doppler is considered as a very sensitive
method for detecting blood ﬂows of low-velocity and low-
volume.3DPowerDopplertechniqueadvantagesincludethe
detection of even minimal blood ﬂow, the reliable analysis of
vesselarchitecture,thevascularisationpatternextendandthe
deﬁnition of the number of vascular poles.
The sensitivity of 3D Power Doppler method is reduced
in some cancers that have undetectable blood ﬂow values
and in some proliferative benign lesions that may present
with increased blood ﬂow and vascularisation. In our study,
3D Power Doppler depicted abnormal vascularisation in
malignant tumors with a relatively low sensitivity (0.53), but
with a high speciﬁcity of 0.97.
Continuous wave and duplex ultrasound studies have
shown that in carcinomas the blood ﬂow is more intense
than in benign lesions. Resistance Index [R.I = (systolic −
diastolic)/systolic] study shows no particular diﬀerence
between malignant and benign tumors [7, 37]. There is
inconsistent information about resistance index and pul-
satility index in breast cancer. This could be explained by
the chaotic, irregular vascular pattern and the presence
of abnormal vessels in malignant tumors with decreased
intratumoral blood ﬂow resistance. On the other hand, loss
of intratumoral tissue elasticity may lead to an increase in
blood ﬂow resistance. The probability to detect a low min
R.I. is strongly inﬂuenced by the number of vessel of cross
sections. So it is not surprising ﬂat most published studies
about diﬀerentiation between benign and malignant tumors
have found signiﬁcantly lower min R.I. in the average better
per fused malignant tumors [38]. Based on Uurjan’s color
Doppler scale we considered and adopted cutof value of
R.I.(I < 0,42) for a malignant breast tumor [39]. In our
study, R.I. was low (<0.42) in 45.3% of malignant cases
(sensitivity 0.44).
In the present study, the combined use of 3D and 3D
PowerDopplerimagingidentiﬁedabreastmassasmalignant
tumor when it appeared with the following characteristics:
irregular shape, abnormal orientation (taller than wider),
ill deﬁned margin, inhomogenous echotexture, absence of
acoustic transmission, retraction or star pattern, chaotic
vessels architecture and sometimes with an RI < 0.42.
Finally, the combined scoring system for sonographic
criteria, that we used for this study have correctly excluded
malignancy in 91.2% of the cases. False positive rate though
was high and, 11.3% of the cases had an ultrasound
cancer diagnosis that was not conﬁrmed histopathologi-
cally (Table 3). As it is reported, preoperative or screening
sonomammography shows an increased sensitivity in breast
cancer diagnosis. Modern modalities improve the ﬁnal
tumorimagingandperhapsthepropertreatmentchoicebut,
they still involve a substantial false positive rate that can
result to unnecessary breast biopsies [2, 3, 40].
5. Conclusion
3D Ultrasound is an eﬀective tool in evaluating the
morphology of breast masses and plays a signiﬁcant and
supplementary role to mammography, especially in dense
mammary tissue. This new technique, based on a speciﬁc
scoring system, gives reliable information and characterizes
the breast tumors. It gives more comprehensive information
onanatomicaldetailsandpathologicalstructuresandoﬀersa
new diagnostic aspect for the diﬀerentiation between benign
and malignant breast lesions. The Power Doppler ﬁndings
should be regarded as additional diagnostic features to the
sonographic evaluation of breast lesions, besides the already
established criteria, with the potential to improve diﬀerential
diagnosis. However, in view of the small number of patients
with breast tumors in our study, these observations should
be considered as preliminary. Further studies are needed to
establish the role of 3D ultrasound in tumor detection and
diﬀerential diagnosis and to determine treatment options.
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